- Acorda Therapeutics Announces Delisting from Nasdaq
- Acorda Therapeutics Announces Nasdaq Delisting Notification
- Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
- Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
- Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
More ▼
Key statistics
On Friday, Acorda Therapeutics Inc (ACORQ:PKC) closed at 0.25, 8.70% above its 52-week low of 0.23, set on Jun 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.23 |
---|---|
High | 0.25 |
Low | 0.23 |
Bid | -- |
Offer | -- |
Previous close | 0.258 |
Average volume | 33.50k |
---|---|
Shares outstanding | 1.24m |
Free float | 1.23m |
P/E (TTM) | -- |
Market cap | 310.52k USD |
EPS (TTM) | -212.10 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 20:59 BST.
More ▼